Bone Marrow Transplantation News

More than half of patients treated with tabelecleucel for Epstein-Barr virus-driven post-transplant lymphoproliferative disease responded to therapy, phase 3 study results showed.

SALT LAKE CITY — Socioeconomic disadvantage among hematopoietic stem cell transplant donors appeared associated with poorer outcomes among transplant recipients, according to study results.

SALT LAKE CITY — Academic center outreach to community practices considerably increased stem cell transplant referrals for patients with multiple myeloma, according to study results.

SALT LAKE CITY — Prevalence of organ dysfunction appeared low among pediatric patients who underwent hematopoietic stem cell transplantation for sickle cell disease, according to retrospective study results.

SALT LAKE CITY — Early azithromycin use did not affect hematologic relapse among pediatric hematopoietic stem cell transplant recipients, according to study results.

SALT LAKE CITY — Patients with relapsed or refractory large B-cell lymphoma who failed chimeric antigen receptor T-cell therapy achieved durable responses with allogeneic hematopoietic stem cell transplantation, according to study results.

SALT LAKE CITY — Treosulfan plus fludarabine conditioning after allogeneic hematopoietic stem cell transplantation conferred better outcomes for patients with myelodysplastic syndrome than a busulfan-based regimen, study results showed.

SALT LAKE CITY — Pediatric and young adult survivors of acute leukemia who underwent allogeneic hematopoietic stem cell transplantation appeared to be at increased risk for late mortality, according to study results.

SALT LAKE CITY — Axatilimab appeared effective for heavily pretreated patients with active chronic graft-versus-host disease, according to phase 1/phase 2 study results.

SALT LAKE CITY — Allogeneic hematopoietic stem cell transplantation appeared effective for patients with high-risk subtypes of acute lymphoblastic leukemia, according to study results.